The latest closing stock price for XTL Biopharmaceuticals as of September 20, 2024 is 2.44.
An investor who bought $1,000 worth of XTL Biopharmaceuticals stock at the IPO in 2005 would have $-996 today, roughly -1 times their original investment - a -24.96% compound annual growth rate over 19 years.
The all-time high XTL Biopharmaceuticals stock closing price was 571.00 on September 01, 2005.
The XTL Biopharmaceuticals 52-week high stock price is 4.99, which is 104.5% above the current share price.
The XTL Biopharmaceuticals 52-week low stock price is 0.75, which is 69.3% below the current share price.
The average XTL Biopharmaceuticals stock price for the last 52 weeks is 1.78.
An investor who bought $1,000 worth of XTL Biopharmaceuticals stock at the IPO in 2005 would have $-996 today, roughly -1 times their original investment - a -24.96% compound annual growth rate over 19 years.
The all-time high XTL Biopharmaceuticals stock closing price was 571.00 on September 01, 2005.
The XTL Biopharmaceuticals 52-week high stock price is 4.99, which is 104.5% above the current share price.
The XTL Biopharmaceuticals 52-week low stock price is 0.75, which is 69.3% below the current share price.
The average XTL Biopharmaceuticals stock price for the last 52 weeks is 1.78.